Conference MiCRObiota Incognita

From September 26th – 28th 2016, Alfonso Benítez-Páez (IATA-CSIC, Spain) will be presenting at Conference MiCRObiota Incognita (Island Krk, Croatia). The conference MiCRObiota Incognita is organised by Biodinamik to educate young scientists about new improvements and innovations in the Microbiome field and motivate them to resolve open questions.

Alfonso’s presentation will discuss MyNewGut and the role of gut microbes as potential therapy against diet-related diseases. You can find an abstract of his presentation through the read more link below. 

Read more

MyNewGut coordinator featured in radio show

Yolanda Sanz, IATA-CSIC, was featured in a Spanish radio show. Here she spoke about the research of the MyNewGut initiative, and its results.

Listen to her feature here (in Spanish).

Trevor Lockett (CSIRO) International BioFest

In late October Trevor Lockett from CSIRO, a MyNewGut partner, will be speaking at the International Bio Fest 2016 (Melbourne, Australia). His lecture is titled “Food, Structure, Bacteria and Health”. Read a preview of the abstract below.


Read more

France Institute for Agricultural Research shares MyNewGut study results at national conferences

This year the INRA team (French National Institute for Agriculural Research) has presented in 4 different conferences in France to share results obtained in the My New Gut human study. This study aimed at evaluating the effects of the quantity and quality of protein intake on the microbiota composition, feces and urinary bacterial metabolite composition, and consequences for the rectal mucosa.

Read more

Peter Holzer discusses new findings at Physiology 2016


On July 31st Peter Holzer represented Medizinische Universitat Graz (MUG), a MyNewGut partner, at Physiology 2016. This was a joint meeting of the American Physiological Society and The Physiological Society (Europe), and took place in Dublin, Ireland.

 He discussed MUG’s new findings obtained within MyNewGut, the message being that a high fat diet (when given to mice for 8 weeks) induces a very distinct depression-like phenotype with an altered gut microbial profile.